The University of Kentucky Markey Cancer Center is an academic, clinical and research center located in Lexington, Kentucky. It was established in 1985, and has grown to 28 departments across eight colleges.

During the past decade, University of Kentucky/Markey Cancer Center conducted 253 clinical trials. In the 10-year time frame, 253 clinical trials started and 213 clinical trials were completed, i.e. on average, 84.2% percent of trials that started reached the finish line to date. In the past 5 years, 104 clinical trials started and 109 clinical trials were completed. i.e. 104.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of Kentucky/Markey Cancer Center" #1 sponsor was "National Cancer Institute (NCI)" with 162 trials, followed by "Children's Oncology Group" with 109 trials sponsored, "SWOG Cancer Research Network" with 57 trials sponsored, "Radiation Therapy Oncology Group" with 30 trials sponsored and "Alliance for Clinical Trials in Oncology" with 30 trials sponsored. Other sponsors include 166 different institutions and companies that sponsored additional 92 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Kentucky/Markey Cancer Center" #1 collaborator was "National Cancer Institute (NCI)" with 288 trials as a collaborator, "NRG Oncology" with 40 trials as a collaborator, "SWOG Cancer Research Network" with 13 trials as a collaborator, "Cancer and Leukemia Group B" with 10 trials as a collaborator and "Canadian Cancer Trials Group" with 9 trials as a collaborator. Other collaborators include 117 different institutions and companies that were collaborators in the rest 83 trials.

According to Clinical.Site data, the most researched conditions in "University of Kentucky/Markey Cancer Center" are "Lung Cancer" (28 trials), "Breast Cancer" (25 trials), "Lymphoma" (19 trials), "Leukemia" (17 trials) and "Prostate Cancer" (14 trials). Many other conditions were trialed in "University of Kentucky/Markey Cancer Center" in a lesser frequency.

Most popular intervention types in "University of Kentucky/Markey Cancer Center" are "Drug" (420 trials), "Other" (225 trials), "Biological" (165 trials), "Radiation" (153 trials) and "Procedure" (137 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (135 trials), "Quality-of-Life Assessment" (61 trials), "Carboplatin" (50 trials), "Cisplatin" (47 trials) and "Cyclophosphamide" (47 trials). Other intervention names were less common.

The vast majority of trials in "University of Kentucky/Markey Cancer Center" are 455 trials for "All" genders, 75 trials for "Female" genders and 23 trials for "Male" genders.

Currently, there are 274 active trials in "University of Kentucky/Markey Cancer Center". 1 are not yet recruiting, 99 are recruiting, 173 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 231 completed trials in University of Kentucky/Markey Cancer Center, 8 suspended trials, and 30 terminated clinical trials to date.

Out of the total trials that were conducted in University of Kentucky/Markey Cancer Center, 69 "Phase 1" clinical trials were conducted, 247 "Phase 2" clinical trials and 216 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 27 trials that are defined as “Not Applicable".